Healthcare Unfiltered

Keeping up with the dietary theme in recent episodes, Chadi hosts Jerry Teixeira (@jerryteixeira), a strength and conditioning expert. He begins with a personal anecdote on how changing his eating habits along with continued regular exercise was necessary to losing weight, divulges exactly what goes into his low-carb diet, shares how alcohol and dessert consumption factors into the diet, explains the benefits of training your muscles to reach temporary muscle failure, breaks down the correlation between strength training and life longevity, and gets into more specifics on his idea of a healthy, sustainable, efficient lifestyle. Visit Jerry’s website for more information on his strength training ideas. https://bodyweightstrength.fit/ Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Chadi is joined by Dave Feldman (@DaveKeto), senior software engineer and entrepreneur, who shares his counterintuitive experience with the ketogenic diet in 2015 and a healthy obsession with the study of lipids and cholesterol that led him to the founding of the “energy model.” Dave breaks down the scientific details of fat cell breakdown in the body, how this process translates in blood tests, and how the “energy model” can be used to elevate one’s health and consumption habits, among a host of other intriguing topics. View Dave’s website to learn more about the “energy model.” https://cholesterolcode.com/ Visit the Citizen Science Foundation website to learn about the lean mass hyper-responder study. https://citizensciencefoundation.org/ Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

In a long overdue appearance, Saurabh Jha (@RogueRad), MD, radiologist in Philadelphia, makes his triumphant return to the show to pick apart the single payer model idea as well as FDA regulatory processes, this time with a worthy adversary: Adam Gaffney (@awgaffney), MD, MPH, pulmonary specialist and health policy researcher at Cambridge Health Alliance/Harvard Medical School. The conversation begins with discussion of a proposed federal single payer system in America, why it could not be modeled after a successful system like that in England, why significant health disparities exist geographically within a single payer system and whether such a system can provide the tools to address these disparities, and so much more. Then, the conversation swings to whether a health care system should be designed to afford high priced novel therapies because of failure to regulate these prices, on what basis the FDA should approve drugs, and other points of discussion. Things get testy in this spirited back-and-forth banter and you won’t want to miss it. Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Mikkael Sekeres (@MikkaelSekeres), MD, chief of the division of hematology at the University of Miami Sylvester Comprehensive Cancer Center, and David Steensma (@DavidSteensma), MD, global hematology head at Novartis, share their recent experiences undergoing career transitions. The physicians dive into a discussion on how often fellowships are given to candidates who are pursuing academic careers, how and why the decisions were made to leave one institution for another (or an institution for industry), whether or not to interview for new positions discreetly, how to approach negotiating aspects of a new employment contract, and so much more. Read Dr. Sekeres' narrative about his move to Miami. https://ascopubs.org/doi/full/10.1200/JCO.21.01070 Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. https://chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. https://www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Sonikpreet Aulakh (@SonikpreetA), MD, assistant professor of medicine at West Virginia University, provides valuable perspective on the transition into the academic world just two years after her fellowship. Dr. Aulakh sheds light on the experience and details of applying for jobs post-fellowship, what types of challenges she may face as a new faculty member, struggles she may encounter as an immigrant and a woman in applying for residency and faculty positions, and plenty more.

Aaron Mitchell (@TheWonkologist), MD, MPH, medical oncologist and health outcomes researcher at Memorial Sloan Kettering Cancer Center, comes on to discuss the shortcomings and pitfalls of the regulatory processes at the FDA, optimal trial endpoints that provide the strongest evidence for approval, whether the accelerated approval process is enforced as it is written, what power any advisory panel really has when it comes to FDA approvals, and so many more pain points today.

Chadi is rejoined by Priya Sampathkumar (@PSampathkumarMD), MD, infectious disease specialist and hospital epidemiologist, Mayo Clinic, to provide a state of affairs for the current COVID-19 situation in America, including why the country has failed to get more of its people vaccinated, why myocarditis has been a frequent side effects in some people, why the delta variant and other future variants come about, whether booster shots should be administered to healthy individuals and those who have had COVID-19 in the past, how safe it is for kids to return to in-person school, and more of the important talking points surrounding the virus at this time.

Vivek Subbiah, MD, associate professor in the department of investigational cancer therapeutics, MD Anderson, is the world-renowned guest on the show this week to tackle the world of precision medicine in cancer. He begins by explaining how precision medicine is more than simply a “fancier” mechanism of treatment than chemotherapy, why tumor sequencing is important even though there aren’t drugs available for every possible mutation, how much the field has advanced even in the past 10 years, the intricacies of designing clinical trials, and lots more.

For another lively debate, Chadi brings on two lymphoma experts to talk about what to do with peripheral T-cell lymphoma (PTCL) patients after an achieved remission: Barbara Pro (@bpromd), MD, Northwestern University, and Mehdi Hamadani (@MediHumdani), MD, Medical College of Wisconsin. The two doctors share how they counsel and treat patients in uncertain situations, including the “right” circumstances to watch-and-wait, autologous transplant, allogeneic transplant, or maintenance chemotherapy.

Chadi welcomes back Rafael Fonseca, (@Rfonsi1), MD, interim director of Mayo Clinic Cancer Center, and Aaron Goodman (@AaronGoodman33), MD, hematologist, University of California San Diego, to debate whether smoldering multiple myeloma should be treated. They begin by agreeing on a definition of the disease, listing patient characteristics that may warrant consideration for early intervention, and stating the importance of improving the ability to predict progressing disease. The trio then debate treatment in specific example circumstances and the overall consensus within the myeloma world, the practicality of clinical trials for smoldering disease, and so much more in this testy and thought-provoking dialogue.